A cohort of cancer patients with no reported cases of SARS-CoV-2 infection: the possible preventive role of Methylene Blue
Título
A cohort of cancer patients with no reported cases of SARS-CoV-2 infection: the possible preventive role of Methylene Blue
Autor
Marc Henry, Mireille Summa, Louis Patrick, Laurent Schwartz
Descripción
We report the case of a cohort of 2500 French patients treated among others with methylene blue for cancer care. During the COVID-19 epidemics none of them developed influenza-like illness. Albeit this lack of infection might be by chance alone, it is possible that methylene blue might have a preventive effect for COVID-19 infection. This is in line with the antiviral activity of Chloroquine, a Methylene blue derivative. Both Chloroquine and Methylene blue have strong antiviral and anti- inflammatory properties probably linked to the change in intracellular pH and redox state.
Fecha
2020
Materia
COVID-19, cancer, methylene blue, metabolic treatment
Identificador
DOI: 10.13128/Substantia-888
Fuente
Substantia
Editor
Firenze University Press
Cobertura
Chemistry, History (General) and history of Europe
Idioma
EN
Archivos
Colección
Citación
Marc Henry, Mireille Summa, Louis Patrick, Laurent Schwartz, “A cohort of cancer patients with no reported cases of SARS-CoV-2 infection: the possible preventive role of Methylene Blue,” SOCICT Open, consulta 17 de abril de 2026, https://www.socictopen.socict.org/items/show/1469.
Position: 5158 (34 views)